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Abstract 
Following reactivation from latency herpesviruses utilize the conserved ability of cell-to-
cell spread to evade the host immune response, mediating disease and viral shedding. The UL51 
protein of herpes simplex virus 1 is a conserved tegument protein that functions in cytoplasmic 
assembly and secondary envelopment. Partial deletions of UL51 are associated with strong cell-
to-cell spread defects. UL51 has no known enzymatic ability suggesting its function in cell-to-
cell spread is likely dependent on specific interactions with other proteins. It has been shown to 
form complexes with UL7, the gE/gI complex and itself. However, it is unknown whether the 
self-interaction is a direct interaction or an interaction mediated by another component. A co-
immunoprecipitation assay using plasmid expression of differentially tagged UL51 proteins 
demonstrates that the UL51 protein does not require other viral proteins for self-interaction. 
Using UL51 truncations coinciding with regions of conservation we began mapping regions 
important for self-interaction through co-immunoprecipitation and co-localization assays. We 
expect that determining the mechanism of interaction that UL51 has with itself will lead to the 
development of ways to determine the significance of the self-interactions for cell-to-cell spread, 
viral assembly or both.  
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Introduction 
Herpes simplex virus 1 is a large double stranded DNA virus that can latently infect sensory 
neurons following primary epithelial infection. The virus can then reactivate causing reoccurring 
symptomatic disease and viral shedding. Herpes simplex virus is ubiquitous; most of the adult 
population has antibodies to either HSV-1 or HSV-2 [2]. Symptomatic disease caused by HSV-1 
most commonly manifests as ulcerative lesions on the epithelia of the lip or genital area. More 
severe infection can occur in neonates following vertical transmission from mother to child and in 
immunocompromised individuals [3]. While more rare, herpesviral encephalitis can result in death 
and herpesviral keratitis is the leading cause of infectious blindness in developed countries [4] [5]. 
HSV-1 is one of eight human herpesviruses that cause varying levels of disease in both 
immunocompetent and immunocompromised individuals, all of which share the ability to establish 
and reactivate from latency. Studying the conserved processes and gene products associated with 
reactivation in HSV-1 can lead to further understanding of all herpesviruses.  
For symptomatic disease to reoccur, HSV-1 must travel from sensory neurons to 
epithelial cells and between epithelial cells following reactivation from latency [6]. This requires 
a way for the virus to evade the adaptive immune response mounted during primary infection in 
order to avoid neutralization. One way that herpesviruses do this is through a conserved process 
called cell to cell spread. After assembly and envelopment mature virions are trafficked to 
junctional surfaces of cells where they are released. In this space, antibodies and effector cells of 
the immune system are unable to inactivate viruses due to steric protection of the cell junction 
[7-9] Through this immune evasion process HSV-1 can travel from neural ganglia to epithelial 
cells to cause disease and viral shedding.  Cell to cell spread is a conserved ability of all 
herpesviruses that is necessary for symptomatic reactivation of disease, but details of this process 
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remain unknown [6, 10-16]. Understanding this process and the conserved viral genes associated 
with it can lead to the development of ways to inhibit this ability. Novel therapeutics could be 
developed to stop spread thus inhibiting recurrent disease. Engineering a virus unable to spread 
from a site of latency may be a viable candidate for the development of a live attenuated vaccine.  
Cell to cell spread is considered the final step in the viral assembly and egress pathway. 
All herpesviruses egress by similar mechanisms of reconstructing host membranes [17]. Capsids 
are assembled in the nucleus but are 
too large to be exported through the 
nuclear pore. In order to exit the 
nucleus they bud through the nuclear 
membrane into the perinuclear space 
and de-envelope at the outer nuclear 
membrane [17].	 The capsids then 
undergo cytoplasmic assembly 
where tegument proteins assemble on 
the capsid and on the membrane of 
the trans golgi network. The capsids then bud into the trans golgi network in a process known as 
secondary envelopment where they acquire the final envelope. The mature virion can then be 
trafficked to the cell membrane for extracellular release or to cellular junctions for cell to cell 
spread (Figure 1).   
Several gene products are involved in HSV-1 cell to cell spread and can be classified into 
two categories—those required for viral entry into the cell and those required for trafficking viral 
components and virions to the cell junctions for spread. In the second category, which is the focus 
Figure 1. Schematic diagram of HSV-1 egress 
pathway. Assembled capsids are represented as gray 
hexagons.  
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of this project, several gene products have been found to be important. The HSV-1 glycoprotein 
gE forms a complex with another glycoprotein gI that localizes at cell junctions and is required for 
efficient cell to cell spread [18].  A complex of UL11, UL16 and UL21 must form on the 
cytoplasmic tail of gE in order for it to be correctly trafficked to these junctions and function in 
cell to cell spread [19]. Another conserved gene product, UL7, is a tegument protein involved in 
virion formation and egress [20]. UL7 forms a complex with another conserved protein, UL51 
[21]. UL51 is a conserved tegument protein that has cell type specific functions in viral growth 
and cell to cell spread [22].  
This project focuses on UL51, a 
30 kDa palmitoylated tegument protein 
that associates with Golgi membranes 
[23]. Strong cell to cell spread defects 
are associated with partial deletions of 
UL51 [22, 24] . The protein has no 
known enzymatic activity and no 
homology to any enzymes, therefore, 
UL51 function is likely dependent on interactions with other viral and cellular factors. It is a 
membrane associated protein making it ideally located for interactions in both secondary 
envelopment and trafficking of vesicles following packaging and the envelopment compartment 
(Figure 2).  UL51 interacts with the gE/gI complex which is likely important in trafficking of gE 
to cell junctions during cell to cell spread [22] . However, a deletion of UL51 causes a more severe 
cell to cell spread defect than gE suggesting that UL51 has other functions in cell to cell spread 
Figure 2. Schematic diagram of hypothetical UL51 
function in secondary envelopment. Capsids are 
denoted by gray hexagons. 
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that may involve other interactions [22]. UL51 also interacts with UL7 which is necessary for the 
recruitment of UL7 into the virion during cytoplasmic assembly [21].   
 UL51 has been observed to interact with itself in virally infected cells, but whether this 
interaction is directly between two UL51 proteins or facilitated by another viral or cellular factor 
is unknown [R. Roller unpublished]. The human cytomegalovirus protein UL71, a homolog of 
UL51, is an important mediator in secondary envelopment and trafficking [25]. UL71 forms a 
homodimer in a direct interaction that is necessary for secondary envelopment. This interaction is 
facilitated by a leucine zipper like domain [26]. This provides further evidence that UL51 interacts 
with itself during secondary envelopment, but since UL51 does not contain a leucine zipper like 
domain it would do so by a different mechanism.  
 This evidence suggests that UL51 interacts with itself in the absence of other viral 
proteins. To test this, we established a co-immunoprecipitation assay using differentially tagged 
UL51 proteins expressed by plasmids. We then began mapping regions important for this 
interaction using UL51 truncations that coincided with regions of UL51 amino acid 
conservation. Once the UL51 self-interaction mechanism is determined we can then determine if 
this self-interaction is important for cell to cell spread, viral assembly or both. 
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Materials and Methods 
Cell Lines   
293T cells were maintained in Dulbecco’s modified Eagle medium supplemented with 
10% fetal bovine serum. Vero cells were maintained as previously described [27]. 
 
Plasmid Construction 
 The plasmid encoding for UL51-HA was constructed by PCR amplification, restriction 
enzyme digestion and ligation into pcDNA3 UL51-FLAG. The UL51-HA coding sequence was 
amplified from a BAC containing the HSV-1 strain F genome with an HA tagged UL51. The PCR 
product was cut with restriction enzymes HincII, BsrGI and XbaI. The restriction enzyme digest 
product was then ligated into pcDNA3 encoding UL51-FLAG at the BsrGI site in UL51 and XbaI 
site in pcDNA3.   
Gibson assembly was used for the creation of plasmids encoding for 1-244 gD-UL51-
FLAG, 1-167 gD-UL51-FLAG and 1-125 gD-UL51-FLAG. A previously constructed pcDNA3  
 
Table	1.	Oligonucleotide	primers	used	in	plasmid	construction.	
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encoding gD-FLAG served as a template for the two vector fragments. A previously constructed  
UL51-FLAG pcDNA3 was used as the template for the insert fragment. Equimolar amounts of 
each fragment were joined using Gibson assembly master mix (New England Biolabs) according 
to the manufacturer’s protocol. Primers used for amplification of all vector fragments and UL51 
insert fragments are described Table 1. Plasmids encoding for UL51-FLAG, 1-167 UL51-FLAG, 
1-125 UL51-FLAG, 1-90 UL51-FLAG, 91-244 UL51-FLAG, 125-244 UL51-FLAG and 
167-244 UL51-FLAG were previously constructed (R. Roller unpublished).    
 
Immunopurification 
293T cells were seeded into 60 mm tissue culture dishes and transfected using 
polyethylanimine (PEI). The amount of PEI used was based on a 3:1 DNA (µg) to PEI (µg) ratio. 
48-hours post transfection, cells were washed with phosphate buffered saline, scraped into 1 mL 
of PBS and pelleted at 2000 rpm for 2 minutes. Cells were resuspended and lysed in 500 µl of PI 
RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X 100, 5 mM Na 
Vanadate, 5 mM NaF). The cell lysate was then sonicated for 10 seconds and cell debris was 
pelleted by centrifugation at 14,000 rpm for 2 minutes. Following removal of 20 µl of the resulting 
supernatant as a lysate control, 8 µl of a-FLAG magnetic beads suspended in PI RIPA buffer were 
added to the remaining supernatant. Samples were incubated overnight at 4°C on an end-over-end 
rotator. Using a magnetic separator, magnetic beads were washed 4 times in500 µl PI RIPA buffer. 
Bound protein was eluted on a magnetic separator 3 times in 20 µl elution buffer containing 167 
µg/mL 3X FLAG peptide (Sigma).  
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SDS-PAGE and Immunoblotting 
 Lysate samples and purified protein samples were separated by sodium dodecyl sulfate-
polyacrylamine gel electrophoresis (SDS-PAGE) and electrically transferred to nitrocellulose by 
standard methods [28]. Membranes were blocked in 5% nonfat milk with .02% Tween 20 for at 
least 1 hour. Membranes were probed with either a mouse anti-HA monoclonal antibody (1:500) 
or a mouse anti-FLAG M2 monoclonal antibody (1:500; Sigma-Aldrich) followed by an alkaline 
phosphatase-conjugated goat a-mouse secondary antibody (1:1000). 
 
Indirect Immunofluorescence 
 Vero cells for imaging were grown in 24-well plates on coverslips until 50% confluent. 
500 ng of DNA was transfected using Lipofectamine reagent according to the manufacturer’s 
protocol. Preparation for immunofluorescence was performed as previously described [29].  
Cells were probed with mouse anti-HA monoclonal antibody (1:500) and mouse anti-FLAG M2 
monoclonal antibody (1:500; Sigma-Aldrich). Secondary antibodies used were donkey anti-
mouse AlexaFluor 488 (1:1000) and donkey anti-goat AlexaFluor 568 (1:1000). Cells were 
mounted on coverslips using ProLong Diamond Antifade Mountant (Invitrogen) according to the 
manufacturer’s protocol. Images for gD-UL51-FLAG co-localization with UL51-HA were 
acquired using confocal microscopy and ImageJ Software as previously described [30]. Images 
for UL51-FLAG truncation localization were acquired using a Leica epifluorescence microscope 
and ImageJ Software.  
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Results	
UL51	does	not	require	other	viral	factors	for	self-interaction	
	 To	 determine	 whether	 UL51	 interacts	 with	 itself	 in	 the	 absence	 of	 other	 HSV-1	 viral	
proteins	 we	 performed	 a	 co-immunoprecipitation	 assay	 of	 transfected	 cell	 lysate	 containing	
differentially	 tagged	 UL51	 proteins.	 Plasmids	 containing	 UL51-HA	 and	 UL51-FLAG	 were	 co-
transfected	 into	293T	cells.	UL51-FLAG	was	purified	from	cell	 lysate	using	anti-FLAG	magnetic	
beads	and	presence	of	both	proteins	were	detected	by	 immunoblot	 (Figure	4).	UL51-HA	and	
UL51-FLAG	were	both	successfully	transfected	and	expressed	well	in	the	lysate	and	UL51-FLAG		
	
Figure	4.	Co-immunoprecipitation	of	UL51-HA	and	UL51-FLAG	in	transfected	cells.	Digital	images	
of	immunoblots	are	shown.	Cells	transfected	with	indicated	constructs	were	lysed,	separated	by	
SDS-Page	 and	 immunoblotted	 as	 described	 in	methods.	 Left	 hand	 panels	 show	 lysate	 proteins	
before	immunopurification	and	right	hand	panels	show	proteins	in	purified	fractions.		
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was	 enriched	 following	 FLAG	 purification.	 UL51-HA	was	 detected	 in	 the	 anti-HA	 immunoblot	
following	 pull	 down	 of	 UL51-FLAG	 in	 co-transfected	 cells	 (Lower	 right	 panel,	 Figure	 4).	 This	
suggests	that	UL51-HA	was	interacting	with	UL51-FLAG	in	transfected	cells	without	the	presence	
of	other	viral	proteins.		
When	UL51-HA	was	transfected	alone,	it	was	also	present	following	purification	for	FLAG	
(Figure	4).		This background suggests that there is non-specific binding occurring between UL51-
HA and the anti-FLAG magnetic beads. However, band intensity in the co-transfected UL51-
HA/UL51-FLAG lane was significantly greater than the background. This was true for 10 
immunoblots showing self-interaction, each showing various levels of background. UL51 
undergoes several post-translational modifications including palmitoylation and phosphorylation. 
In a transfected cell lysate several species of UL51 are present due to the proteins being at different 
stages of modification. The UL51 species are slightly different sizes and run as multiple bands on 
SDS-PAGE gels around 30 kDa (Figure 4).  
 
Amino Acids 91-244 are sufficient for UL51 self-interaction 
The UL51 protein can be broken down into four regions of conservation (Figure 5A). In 
order to determine the importance of these regions in UL51 self-interaction, truncations whose 
boundaries coincide with the boundaries of the regions of conservation of UL51 were created 
(Figure 5B).  
To begin mapping regions of the protein important for self-interaction we repeated the co-
immunoprecipitation assay used previously with UL51-HA and the N terminal UL51-FLAG 
truncations.	 Full	 length	 UL51-FLAG	 (1-244)	 expressed	 well	 in	 the	 lysate.	 91-244	 UL51-FLAG	
and125-244	UL51-FLAG	were	expressed	less	than	the	full-length	protein	in	the	lysate	and	167-
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244	UL51-FLAG	was	not	detected	by	immunoblot	in	the	lysate	(Figure	6).	All	FLAG	tagged	UL51	
proteins	were	enriched	by	purification	with	anti-FLAG	magnetic	beads.	91-244	and	125-244	were	
enriched	enough	following	purification	to	be	able	to	compare	their	pull-down	ability	of	UL51-HA.		
Once	again,	UL51-HA	was	detected	in	the	anti-HA	immunoblot	after	purification	with	full	length	
UL51-FLAG	suggesting	self-interaction.	Similarly,	UL51-HA	was	detected	in	the	91-244	lane	as	a	
more	intense	band	than	the	background.	UL51-HA	had	similar	band	intensity	in	the	125-244,	167-
244	and	UL51-HA	only	lanes	(Figure	6).	This	suggests	that	any	UL51-HA	detected	in	these	lanes	is	
due	to	non-specific	binding	of	UL51-HA	to	the	anti-FLAG	magnetic	beads.	These	results	suggest	
that	amino	acids	91-244	are	sufficient	for	self-interaction	and	amino	acids	125-244	are	not. 
	
B	
A	
Figure 5. UL51 sequence conservation and truncation constructs. (A) Plot showing the 
conservation of amino acids using all available herpesvirus UL51 homologous sequences. Sequences 
were aligned using MUSCLE  [1]. (B) Schematic diagram of FLAG tagged (red) UL51 constructs 
used in this study and their alignment with regions of conservation in UL51.  
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To gather additional evidence supporting self-interaction we performed a co-localization 
assay using N terminal UL51-FLAG truncations and full length UL51-HA (Figure 7). Full length 
UL51-HA localizes to the golgi apparatus in transfected cells. The N terminal truncations are all 
missing the site of palmitoylation at amino acid position 9 and are therefore unable to associate 
with membranes in transfected cells. They localize diffusely throughout the cytoplasm and 
nucleus when transfected alone (R. Roller unpublished). Upon co-transfection, UL51-HA was 
able to recruit 91-244 UL51-FLAG to the golgi apparatus (A-C Figure 7). The 125-244 
truncation was unable to recruit the full length UL51-HA and remained diffused throughout the 
cytoplasm (D-F). Interestingly, the 167-244 truncation showed recruitment by UL51-HA in some 
of the cells imaged (G-I). These results support the claim that amino acids 91-244 are sufficient 
for self-interaction and 125-244 is not. However, the results also suggest that amino acids 167-
244 are sufficient for this self-interaction as well. 
Figure	 6.	 Interaction	 between	 UL51-FLAG	 truncations	 and	 UL51-HA	 in	 transfected	 cells.	Digital	
images	 of	 immunoblots	 are	 shown.	 Cells	 were	 co-transfected	 with	 UL51-FLAG	 constructs	 with	
indicated	UL51	length	and	UL51-HA.	UL51-HA	transfected	alone	and	mock	were	used	as	controls.	Cells	
were	lysed,	separated	by	SDS-PAGE	and	immunoblotted	as	described	in	methods.	Left	hand	panels	
show	cell	 lysate	proteins	before	 immunopurification	and	 right	hand	panels	 show	purified	protein	
fractions.		
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UL51-FLAG C terminal truncations express poorly in transfected cells 
 To continue mapping regions of UL51 important for self-interaction we attempted to carry 
out another co-immunoprecipitation assay using UL51-HA and the C terminal UL51-FLAG 
truncations. Full length UL51-FLAG was transfected and expressed efficiently (Figure 8). 1-167 
Figure 7. Localization of UL51-FLAG truncations and UL51-HA in transfected cells.  Three 
representative merged images are shown for each N terminal truncation. Images of ten randomly 
selected cells were taken for each construct. FLAG is shown in red, HA is shown in green and co-
localization is indicated by yellow. Cells were co-transfected with UL51-HA and either 91-244 
UL51 FLAG (A-C), 125-244 UL51-FLAG (D-F) or 167-244 UL51-FLAG (G-I) and imaged using 
methods as described.  
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UL51-FLAG was not able to be detected in the lysate by immunoblot and was only slightly 
enriched following purification. 1-125 UL51-FLAG was not detected in the lysate immunoblot or 
the immunoblot following purification. These results suggest that the C terminal truncations are 
not being expressed at a high enough level in transfected cells to successfully do the established 
co-immunoprecipitation assay previously used with the N terminal truncations.  
	
	
	
	
	
 
gD-UL51 fusion proteins do not interact with UL51-HA 
To obtain better expression of the UL51-FLAG C terminal truncations we fused UL51 to 
the highly expressed glycoprotein, gD.  All constructs were expressed well in the lysate and 
enriched by immunoprecipitation (Figure 9A). However, UL51-HA was not detected in any lanes 
following purification with anti-FLAG magnetic beads (Figure 9A). Since it was previously shown 
that the full length UL51-FLAG is able to co-purify UL51-HA, the negative results in the full 
length (1-244) gD-UL51-FLAG lane suggests that gD-UL51-FLAG fusion proteins are not 
suitable candidates for interaction with UL51-HA.  
Figure 8. UL51-FLAG C terminal truncation expression in transfected cells. Digital 
images of immunoblots are shown. Cells were transfected with UL51-FLAG constructs with 
indicated UL51 length. Lysate and purified protein fractions were separated by SDS-Page 
and immunoblotted as described in methods. 
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 In order to confirm these results, the full length gD-UL51-FLAG was co-transfected with 
UL51-HA and localization of the proteins was visualized by immunofluorescence. When 
transfected alone, UL51-HA has been shown to localize to the golgi apparatus and gD-UL51-
FLAG localizes to the endoplasmic reticulum. When co-transfected gD-UL51-FLAG was unable 
to recruit UL51-HA and vise versa (Figure 9B). These results confirm that when gD is fused to 
UL51-FLAG, UL51 is unable to self-interact in transfected cells. This makes these constructs 
unsuitable for a UL51 self-interaction co-immunoprecipitation assay or a co-localization assay in 
transfected cells.  
	
	
	
	
A	
B	
Figure 9. gD-UL51-FLAG does not co-localize with UL51HA in transfected cells. (A) Digital 
images of western blots are shown. Cells were co-transfected with gD-UL51-FLAG constructs with 
indicated UL51 length and UL51-HA. Lysate and purified protein fractions were separated by SDS-
Page and immunoblotted as described in methods. (B) A representative image selected from ten 
randomly selected cells showing efficient transfection is shown. Cells were co-transfected with 
indicated constructs and prepared for immunofluorescence imaging as described in methods.  
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Discussion	
UL51 is a palmitoylated tegument protein conserved across all herpesviruses [31]. 
Palmitoylation of the protein allows for membrane association and has been shown to facilitate 
localization to the golgi apparatus in transfected and infected cells [23]. Incorporation of UL51 
into the tegument of mature virions suggests that UL51 localizes to the exterior of cellular 
membranes.  This places UL51 in a prime position for participating in both virion assembly and 
trafficking interactions.  UL51 has previously been shown to interact with UL7 which is required 
for UL7 incorporation into the virion making it an important interaction in viral assembly [21]. 
Also, UL51 interacts with the gE/gI complex which plays a role in virion trafficking[22]. 
Previous studies suggest that UL51 may also interact with itself [32]. Due to the known role of 
UL51 in cell to cell spread it is likely that this self-interaction is also an important interaction in 
the assembly and egress pathway of herpesviruses.  
Here, we confirm UL51 self-interaction and show that this interaction does not require 
other viral factors. What remains unknown is whether this interaction is a direct interaction 
between two UL51 proteins or if there is a cellular component mediating the interaction. In order 
to differentiate these two scenarios, further studies could be performed using two bacterially 
derived UL51 fusion proteins. Fusion of UL51 to glutathione S-transferase and maltose binding 
protein would provide a means for establishing a co-immunoprecipitation assays similar to the 
one used in this study. Interaction observed in this environment would confirm that UL51 is 
directly interacting with itself in the absence of viral proteins and cellular proteins.  
Determining the importance of this interaction, whether direct or indirect, requires a way 
to inhibit it. This would allow for observation of the phenotype of a virus expressing UL51 that 
is unable to interact with itself. In order to create such a UL51 mutant that inhibits only self-
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interaction function but no other interactions we aimed to determine the amino acids important 
for interaction. By using both C terminal and N terminal truncations of UL51 that coincide with 
regions of amino acid conservation of the protein we could potentially determine which region is 
important for self-interaction.  
The N terminal truncation UL51 constructs expressed well enough to be able to 
preliminarily determine that amino acids 91-244 are sufficient for the interaction. Our results 
from both the co-immunoprecipitation assay and co-localization assay suggest that amino acids 
125-244 are not sufficient for self-interaction, indicating that amino acids 91-125 are important 
for interaction. Interestingly, in the co-localization assay some cells transfected with the 167-244 
truncation showed co-localization with full length UL51-HA at the golgi. If confirmed that the 1-
167 UL51 truncation is able to self-interact this may suggest that there are two possible 
interactions sites- one in amino acids 91-125 one in 167-244. It is difficult to predict the effect 
that truncating a protein may have on secondary and tertiary structure. It is possible that the 125-
244 truncation folds improperly and blocks the interaction site located in the 167-244 area, thus 
blocking self-interaction. The 167-244 truncation may still be able to fold properly in order to 
self-interact. To confirm these results C terminal truncations would be necessary to show that 
constructs containing the 91-125 region would be sufficient for self-interaction but that amino 
acids 1-90 are insufficient. Interestingly, UL51 amino acids 30-60 have been shown to be 
sufficient for interaction with UL7. If the UL51 self-interaction domain is indeed not in amino 
acids 1-90 this could suggest that UL51 is able to interact with both itself and UL7 at the same 
time. 
Expression of the C terminal truncations was not high enough to be able to perform the 
established co-immunoprecipitation assay. In an attempt to increase expression of these 
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constructs we used a method previously used when characterizing the interaction between UL51 
and UL7. There were previous issues expressing 1-90 UL51-FLAG so the truncation was fused 
to the highly expressing glycoprotein, gD. This fusion increased expression and changed 
localization in transfected cells from the golgi to the endoplasmic reticulum. UL7 is a soluble 
protein and localizes diffusely in the cytoplasm and nucleus. A co-localization assay was 
performed which showed recruitment of UL7 to the endoplasmic reticulum suggesting 
interaction between the UL51 truncation and UL7. We hypothesized that this method could be 
used for the rest of the UL51 truncations and used in co-localization and co-immunoprecipitation 
assays with UL51-HA. However, the gD fusion proteins were unable to pull down UL51-HA and 
did not co-localize in the cell. The exact reason why this occurred is unknown. It may be due to 
the fact that UL51 and gD are both membrane associated proteins that localize to different 
compartments. Therefore, the proteins are sterically hindered from interacting with each other. 
Fusing gD to UL51 may also disrupt folding of UL51, inhibiting self-interaction. 
Another method to determine which C terminal truncations are able to self-interact is to 
do further co-localization assays. The C terminal truncations, like full length UL51, would 
localize to the golgi in transfected cells. An HA tagged UL51 mutant with a C9V mutation could 
be used as bait for the assay. This mutation prevents palmitoylation of UL51 causing the protein 
to localize diffusely in the cytoplasm. Upon co-transfection of full length UL51-FLAG and the 
mutant UL51-HA, we would expect recruitment of C9V UL51-HA to the golgi apparatus. This 
can then be compared to recruitment by the C terminal truncations which would provide 
evidence as to which amino acids are contributing to self-interaction. 
The eventual goal of these experiments is to determine whether this interaction is 
important in cell to cell spread, viral assembly or both. Once a region of interaction is 
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determined, point mutants of the protein could be created and screened for loss of self-interaction 
function. This mutant UL51 could then be incorporated into a recombinant virus and viral 
growth and spread could be measured.  This knowledge would further characterize the 
importance of UL51 interactions with viral proteins in the assembly and egress pathway of 
herpesviruses.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 21	
Acknowledgments 
	
	 I would like to thank Dr. Roller for his continued guidance and support as my mentor 
throughout this project. I would also like to thank current and past lab members Ali Haugo-
Crooks, Carly Twigg, Amber Vu, Gunther Hansen, Shondra Olson, Masoudeh Bahnamiri and 
Bridget Moricz. Finally, I would like to thank the Department of Microbiology and Immunology 
for funding and for providing the opportunity to pursue novel research as an undergraduate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 22	
Literature Cited 
 
1. Edgar, R.C., MUSCLE: multiple sequence alignment with high accuracy and high 
throughput. Nucleic Acids Research, 2004. 32(5): p. 1792-1797. 
2. Whitley, R.J. and B. Roizman, Herpes simplex viruses, in Clinical Virology, D. Richman, 
R.J. Whitley, and F.G. Hayden, Editors. 2002, ASM Press: Washington, DC. p. 375-401. 
3. Kimberlin, D.W. and R.J. Whitley, Neonatal herpes: what have we learned. Semin 
Pediatr Infect Dis, 2005. 16(1): p. 7-16. 
4. Steiner, I. and F. Benninger, Update on herpes virus infections of the nervous system. 
Curr Neurol Neurosci Rep, 2013. 13(12): p. 414. 
5. Farooq, A.V. and D. Shukla, Herpes simplex epithelial and stromal keratitis: an 
epidemiologic update. Surv Ophthalmol, 2012. 57(5): p. 448-62. 
6. Sacks, S.L., et al., HSV shedding. Antiviral Research, 2004. 63, Supplement 1(0): p. 
S19-S26. 
7. Mingo, R.M., et al., Replication of Herpes Simplex Virus: Egress of Progeny Virus at 
Specialized Cell Membrane Sites. Journal of Virology, 2012. 86(13): p. 7084-7097. 
8. Johnson, D.C., et al., Herpes Simplex Virus gE/gI Sorts Nascent Virions to Epithelial Cell 
Junctions, Promoting Virus Spread. J. Virol., 2001. 75(2): p. 821-833. 
9. Farnsworth, A. and D.C. Johnson, Herpes Simplex Virus gE/gI Must Accumulate in the 
trans-Golgi Network at Early Times and Then Redistribute to Cell Junctions To Promote 
Cell-Cell Spread. J. Virol., 2006. 80(7): p. 3167-3179. 
10. Arbuckle, J.H. and P.G. Medveczky, The molecular biology of human herpesvirus-6 
latency and telomere integration. Microbes and Infection, 2011. 13(8–9): p. 731-741. 
11. Beaulieu, B.L. and J.L. Sullivan, Epstein-Barr Virus, in Clinical Virology, D. Richman, 
R.J. Whitley, and F.G. Hayden, Editors. 2002, ASM Press: Washington, DC. p. 479-494. 
12. Di Luca, D., et al., Human herpesviruses 6 and 7 in salivary glands and shedding in 
saliva of healthy and human immunodeficiency virus positive individuals. J. Med. Virol., 
1995. 45(4): p. 462-468. 
13. Gershon, A.A. and M.D. Gershon, Pathogenesis and Current Approaches to Control of 
Varicella-Zoster Virus Infections. Clin Microbiol Rev, 2013. 26(4): p. 728-743. 
14. Giffin, L. and B. Damania, Chapter Two - KSHV: Pathways to Tumorigenesis and 
Persistent Infection, in Advances in Virus Research, M. Karl and A.M. Frederick, 
Editors. 2014, Academic Press. p. 111-159. 
15. Griffiths, P.D. and V.C. Emery, Cytomegalovirus, in Clinical Virology, D. Richman, R.J. 
Whitley, and F.G. Hayden, Editors. 2002, ASM Press: Washington, DC. p. 433-461. 
16. Widmer, I.C., et al., Human herpesvirus 8 oral shedding in HIV-infected men with and 
without Kaposi sarcoma. Journal of Acquired Immune Deficiency Syndromes, 2006. 
42(4): p. 420-425. 
17. Johnson, D.C. and J.D. Baines, Herpesviruses remodel host membranes for virus egress. 
Nat Rev Micro, 2011. 9(5): p. 382-394. 
18. Dingwell, K.S., et al., Herpes simplex virus glycoproteins E and I facilitate cell-to-cell 
spread in vivo and across junctions of cultured cells. Journal of Virology, 1994. 68: p. 
834-845. 
19. Han, J., et al., Function of glycoprotein E of herpes simplex virus requires coordinated 
assembly of three tegument proteins on its cytoplasmic tail. Proceedings of the National 
Academy of Sciences, 2012. 109(48): p. 19798-19803. 
	 23	
20. Fuchs, W., et al., The UL7 gene of pseudorabies virus encodes a nonessential structural 
protein which is involved in virion formation and egress. J Virol, 2005. 79(17): p. 11291-
9. 
21. Roller, R.J. and R. Fetters, The Herpes Simplex Virus 1 UL51 Protein Interacts with the 
UL7 Protein and Plays a Role in Its Recruitment into the Virion. Journal of Virology, 
2015. 89(6): p. 3112-3122. 
22. Roller, R.J., et al., The Herpes Simplex Virus 1 UL51 Gene Product Has Cell Type-
Specific Functions in Cell-to-Cell Spread. J Virol, 2014. 88(8): p. 4058-68. 
23. Nozawa, N., et al., Subcellular Localization of Herpes Simplex Virus Type 1 UL51 
Protein and Role of Palmitoylation in Golgi Apparatus Targeting. J. Virol., 2003. 77(5): 
p. 3204-3216. 
24. Klupp, B.G., et al., Functional Analysis of the Pseudorabies Virus UL51 Protein. J. 
Virol., 2005. 79(6): p. 3831-3840. 
25. Schauflinger, M., et al., The tegument protein UL71 of human cytomegalovirus is 
involved in late envelopment and affects multivesicular bodies. J Virol, 2011. 85(8): p. 
3821-32. 
26. Meissner, C.S., et al., A leucine zipper motif of a tegument protein triggers final 
envelopment of human cytomegalovirus. J Virol, 2012. 86(6): p. 3370-82. 
27. Roller, R.J., et al., Herpes simplex virus type 1 UL34 gene product is required for viral 
envelopment. Journal of Virology, 2000. 74: p. 117-129. 
28. Sambrook, J., E.F. Fritsch, and T. Maniatis, Molecular cloning; A laboratory manual. 2 
ed. 1989, New York: Cold spring harbor laboratory press. 
29. Bjerke, S.L., et al., Effects of charged cluster mutations on the function of herpes simplex 
virus type 1 UL34 protein. J. Virol., 2003. 77: p. 7601-7610. 
30. Reynolds, A.E., et al., UL31 and UL34 proteins of herpes simplex virus type 1 form a 
complex that accumulates at the nuclear rim and is required for envelopment of 
nucleocapsids. J. Virol., 2001. 75: p. 8803-8817. 
31. Nozawa, N., et al., Herpes Simplex Virus Type 1 UL51 Protein Is Involved in Maturation 
and Egress of Virus Particles. J. Virol., 2005. 79(11): p. 6947-6956. 
32. Albecka, A., et al., Dual Function of the pUL7-pUL51 Tegument Protein Complex in 
Herpes Simplex Virus 1 Infection. J Virol, 2017. 91(2). 
 
